Browse the latest research summaries in the field of pain management for spinal cord injury patients and caregivers.
Showing 261-270 of 682 results
Interventional Pain Medicine, 2023 • April 25, 2023
This case report describes a rare instance of immediate post-operative paraplegia following spinal cord stimulator implantation with a paddle electrode in a 70-year-old male. Despite prompt interventi...
KEY FINDING: A 70-year-old male developed immediate post-operative incomplete paraplegia following spinal cord stimulator implantation with a thoracic paddle electrode.
Interventional Pain Medicine, 2023 • April 27, 2023
This case report describes the successful use of spinal cord stimulation (SCS) to treat pain-induced autonomic dysreflexia (AD) in a 46-year-old female with chronic incomplete traumatic quadriplegia. ...
KEY FINDING: The patient experienced a significant reduction in AD episodes following SCS implantation, with a reported 75% improvement in AD symptoms three months after the procedure.
Interventional Pain Medicine, 2023 • January 2, 2023
This case report describes an 83-year-old male who developed anterior spinal artery syndrome (ASAS) nine days after undergoing kyphoplasty for a T8 vertebral compression fracture. The ASAS was caused ...
KEY FINDING: A rare case of delayed-onset ASAS occurred nine days after kyphoplasty, caused by retropulsion of a bone fragment from a refractured vertebral body.
Interventional Pain Medicine, 2023 • November 2, 2023
This case report describes a patient who suffered a spinal cord injury following a cervical epidural injection. The patient had a history of prior cervical surgery and received the injection for uncon...
KEY FINDING: A patient developed a spinal cord injury (SCI) after an interlaminar cervical epidural injection (CEI).
Spinal Cord, 2024 • September 12, 2024
This manuscript describes the rationale and components of the EEG neurofeedback intervention designed for individuals with SCI neuropathic pain and intended for home-based implementation. The EEG neur...
KEY FINDING: EEG neurofeedback may offer clinically meaningful benefits in pain intensity and pain interference for individuals with chronic pain.
CNS Neurosci Ther, 2024 • January 1, 2024
This study aimed to determine if the combined application of CLP290 and bumetanide maximizes the improvement of neuropathic pain following spinal cord injury (SCI) and to elucidate its potential molec...
KEY FINDING: The combined treatment of CLP290 and bumetanide provided the most significant improvement in restoring Rate-Dependent Depression (RDD) levels.
Brain Communications, 2024 • August 19, 2024
This study demonstrates that intraspinal microstimulation (ISMS) of the ventral horn can simultaneously reduce neuropathic pain and improve movement in a rat model of spinal cord injury. The study fou...
KEY FINDING: Intraspinal microstimulation (ISMS) in the ventral horn reduces transmission through nociceptive specific and wide dynamic range neurons in response to pain-related sensory feedback.
Pain Practice, 2025 • January 1, 2025
This study investigated the influence of pain on community reintegration among manual wheelchair users with spinal cord injury (SCI). It examined the associations between neuropathic pain, nociceptive...
KEY FINDING: Most participants (85.2%) reported current pain, with neuropathic pain (53.3%) being more common than nociceptive shoulder pain (14.8%).
PAIN Reports, 2024 • October 8, 2024
This pilot study investigated the analgesic effects of different IVR environments (scenic, somatic) compared with a control environment and explored psychomotor properties influencing pain attenuation...
KEY FINDING: Scenic VR participants showed reduced Neuropathic Pain Symptom Inventory scores postintervention and at follow-up, suggesting pain reduction.
Int. J. Mol. Sci., 2024 • September 24, 2024
The study investigates the efficacy of electroacupuncture (EA) in mitigating neuropathic pain (NPP) in mice by examining the role of adenosine A3 receptors (Adora-3) in the central nervous system. EA ...
KEY FINDING: EA upregulates Adora-3 and CD73 expression while inhibiting ADA expression in the spinal cord dorsal horn (SCDH) of mice with spared nerve injury (SNI)-induced neuropathic pain.